ATYR

aTyr Pharma, Inc. - Common Stock (ATYR)

About aTyr Pharma, Inc. - Common Stock (ATYR)

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Details

Daily high

$6.16

Daily low

$5.60

Price at open

$6.13

52 Week High

$44.40

52 Week Low

$4.07

Market cap

15.2M

Dividend yield

Volume

32,878

Avg. volume

100,044

P/E ratio

-.25

aTyr Pharma, Inc. - Common Stock News